CureVac N.V.
CVACNASDAQHealthcare
$4.66
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio—
52W High$5.72
52W Low$2.475
CureVac N.V. (CVAC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CVAC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.54B | $0.05B | $0.07B | $0.10B | $0.05B |
| Cost of Revenue | $0.11B | $0.12B | $0.18B | $0.24B | $0.01B |
| Gross Profit | $0.43B | ($0.07B) | ($0.12B) | ($0.14B) | $0.03B |
| Gross Margin %(computed) | 80.23% | -131.34% | -172.91% | -131.28% | 71.02% |
| Operating Expenses | |||||
| R&D Expenses | $0.15B | $0.12B | $0.06B | $0.82B | $0.11B |
| G&A Expenses | $0.07B | $0.08B | $0.09B | $0.09B | $0.05B |
| Total Operating Expenses | $0.25B | $0.20B | $0.13B | $0.28B | $0.16B |
| Operating Income | $0.18B | ($0.27B) | ($0.25B) | ($0.41B) | ($0.12B) |
| Operating Margin %(computed) | 33.20% | -510.08% | -370.00% | -400.29% | -253.58% |
| Interest Income | $0.01B | $0.02B | $0.00B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.01B | $0.02B |
| Income Before Tax | $0.19B | ($0.26B) | ($0.25B) | ($0.41B) | ($0.13B) |
| Income Tax Expense | $0.03B | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Income | $0.16B | ($0.26B) | ($0.25B) | ($0.41B) | ($0.13B) |
| Net Margin %(computed) | 30.30% | -483.96% | -369.37% | -399.76% | -263.96% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.72 | $-1.18 | $-1.32 | $-2.21 | $-0.98 |
| Wtd Avg Shares | 0.22B | 0.22B | 0.19B | 0.19B | 0.13B |
| EBITDA | $0.21B | ($0.23B) | ($0.21B) | ($0.39B) | ($0.12B) |
| EBITDA Margin %(computed) | 39.18% | -435.45% | -310.57% | -375.27% | -251.73% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B
Explore more CureVac N.V. data
About CureVac N.V. (CVAC) Income Statement
CureVac N.V. (CVAC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, CVAC reported revenue of $0.54B, gross profit of $0.43B (gross margin 80.23%), and net income of $0.16B — a net profit margin of 30.30%.
Frequently asked questions
CVAC · 4 questionsCureVac N.V. (CVAC) reported revenue of $0.54B for 2024, up 895.5% year-over-year.
CVAC revenueCVAC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08